» Articles » PMID: 38713518

Neuronal DAMPs Exacerbate Neurodegeneration Via Astrocytic RIPK3 Signaling

Abstract

Astrocyte activation is a common feature of neurodegenerative diseases. However, the ways in which dying neurons influence the activity of astrocytes is poorly understood. Receptor interacting protein kinase-3 (RIPK3) signaling has recently been described as a key regulator of neuroinflammation, but whether this kinase mediates astrocytic responsiveness to neuronal death has not yet been studied. Here, we used the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease to show that activation of astrocytic RIPK3 drives dopaminergic cell death and axon damage. Transcriptomic profiling revealed that astrocytic RIPK3 promoted gene expression associated with neuroinflammation and movement disorders, and this coincided with significant engagement of damage-associated molecular pattern signaling. In mechanistic experiments, we showed that factors released from dying neurons signaled through receptor for advanced glycation endproducts to induce astrocytic RIPK3 signaling, which conferred inflammatory and neurotoxic functional activity. These findings highlight a mechanism of neuron-glia crosstalk in which neuronal death perpetuates further neurodegeneration by engaging inflammatory astrocyte activation via RIPK3.

Citing Articles

Dexamethasone-loaded platelet-inspired nanoparticles improve intracortical microelectrode recording performance.

Shoffstall A, Li L, Hartzler A, Menendez-Lustri D, Zhang J, Chen A Res Sq. 2025; .

PMID: 39989959 PMC: 11844648. DOI: 10.21203/rs.3.rs-6018202/v1.


Intercellular Adhesion Molecule 1 (ICAM-1): An Inflammatory Regulator with Potential Implications in Ferroptosis and Parkinson's Disease.

Miller M, Landis H, Miller R, Tizabi Y Cells. 2024; 13(18.

PMID: 39329738 PMC: 11430830. DOI: 10.3390/cells13181554.


Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson's disease.

Eubanks E, VanderSleen K, Mody J, Patel N, Sacks B, Farahani M bioRxiv. 2024; .

PMID: 39257816 PMC: 11384021. DOI: 10.1101/2024.08.30.610195.


Astrocytic RIPK3 exerts protective anti-inflammatory activity during viral encephalitis via induction of serpin protease inhibitors.

Lindman M, Estevez I, Marmut E, DaPrano E, Chou T, Newman K bioRxiv. 2024; .

PMID: 38826345 PMC: 11142122. DOI: 10.1101/2024.05.21.595181.

References
1.
Meller D, Eysel U, Schmidt-Kastner R . Transient immunohistochemical labelling of rat retinal axons during Wallerian degeneration by a monoclonal antibody to neurofilaments. Brain Res. 1994; 648(1):162-6. DOI: 10.1016/0006-8993(94)91917-8. View

2.
Song J, Lee W, Park K, Lee J . Receptor for advanced glycation end products (RAGE) and its ligands: focus on spinal cord injury. Int J Mol Sci. 2014; 15(8):13172-91. PMC: 4159787. DOI: 10.3390/ijms150813172. View

3.
Snyder A, Hubbard N, Messmer M, Kofman S, Hagan C, Orozco S . Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. Sci Immunol. 2019; 4(36). PMC: 6831211. DOI: 10.1126/sciimmunol.aaw2004. View

4.
Langeh U, Singh S . Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders. Curr Neuropharmacol. 2020; 19(2):265-277. PMC: 8033985. DOI: 10.2174/1570159X18666200729100427. View

5.
Sasaki T, Liu K, Agari T, Yasuhara T, Morimoto J, Okazaki M . Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease. Exp Neurol. 2015; 275 Pt 1:220-31. DOI: 10.1016/j.expneurol.2015.11.003. View